📰 Nasdaq Coll News
Page 6 - Nasdaq Coll News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.
May 3, 2022
Equities research analysts forecast that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post sales of $78.95 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest sales estimate is $75.10 million and the highest is $83.27 million. Collegium Pharmaceutical posted sales of $87.72 […]
May 2, 2022
Brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce $0.97 earnings per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $0.82 to $1.03. Collegium Pharmaceutical posted earnings of $0.41 per share in the same quarter last year, which would suggest […]
April 17, 2022
Wall Street brokerages expect that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report $78.95 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $75.10 million to $83.27 million. Collegium Pharmaceutical reported sales of $87.72 million during the same quarter […]
April 13, 2022
Wall Street brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to post earnings of $0.99 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings, with the lowest EPS estimate coming in at $0.87 and the highest estimate coming in at $1.03. Collegium Pharmaceutical reported earnings […]
April 13, 2022
Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Monday, TheStreetRatingsTable reports. Several other research firms have also recently commented on COLL. HC Wainwright boosted their target price on Collegium Pharmaceutical from $26.00 to $29.00 and gave […]
April 13, 2022
Collegium Pharmaceutical (NASDAQ: COLL) recently received a number of ratings updates from brokerages and research firms: 4/11/2022 – Collegium Pharmaceutical was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating. 4/6/2022 – Collegium Pharmaceutical had its price target raised by analysts at Needham & Company LLC from $34.00 to $36.00. They […]
March 25, 2022
Brokerages predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report sales of $79.05 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Collegium Pharmaceutical’s earnings. The highest sales estimate is $83.33 million and the lowest is $75.10 million. Collegium Pharmaceutical posted sales of $87.72 million in the […]
March 5, 2022
Wall Street analysts expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce earnings of $1.10 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest EPS estimate is $0.92 and the highest is $1.21. Collegium Pharmaceutical posted earnings per share of $0.41 during the […]
March 2, 2022
Wall Street analysts predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post $83.53 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $80.58 million to $86.48 million. Collegium Pharmaceutical posted sales of $87.72 million during the same […]